Cabozantinib: prices and alternatives
Indicated for: (1) advanced renal cell carcinoma (RCC), including as first-line therapy in combination with nivolumab; (2) hepatocellular carcinoma (HCC) previously treated with sorafenib; (3) locally advanced or metastatic differentiated thyroid cancer (DTC) progressing after prior VEGFR-targeted therapy in patients…
3 products with this active ingredient from 1 manufacturer.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.


